NCT05490836 Functional Cure Rate of Peg-IFNα-2b Combined With TAF in HBeAg Negative CHB Patients Status UNKNOWN Phase NA
NCT05483049 Prevalence of Significant Liver Fibrosis and Inflammation in Chronic HBV Infected Patients in Grey Zone Status UNKNOWN Phase N/A
NCT05466071 Safety and Efficacy of TAF to Prevent MTCT of HBV in Middle/Late Pregnancies With High HBV DNA Load Status RECRUITING Phase N/A
NCT05457920 Study on Clinical Program Optimization of Inactive Hepatitis B Surface Antigen (HBsAg) Carriers (IHCs) Status UNKNOWN Phase NA
NCT05451420 Inactive HBsAg Carriers (IHCs) Treated With Pegylated Interferon α2b Based Intervention Therapy Status COMPLETED Phase NA
NCT05423834 Chronic Kidney Disease Progression in Chronic Hepatitis B Patients on Tenofovir Alafenamide (TAF) Versus Entecavir Status ACTIVE_NOT_RECRUITING Phase N/A
NCT05414981 A Study to Assess the Safety, Pharmacokinetics, and Antiviral Activity of ABI-H3733 in Subjects With Chronic Hepatitis B Virus Infection Status COMPLETED Phase PHASE1
NCT05410496 Tenofovir Alafenamide Switching Therapy in Kidney or Liver Transplant Recipients With Chronic HBV Infection Status ACTIVE_NOT_RECRUITING Phase PHASE4
NCT05357235 The Study on Optimal Treatment and Clinical Outcome of Chronic Hepatitis B Patients With Inactive Hypoviremia Status UNKNOWN Phase N/A
NCT05357183 The Study on Clinical Outcome and Treatment Optimization of Chronic Hepatitis B Patients With Hypoviremia Status UNKNOWN Phase N/A
NCT05345990 Treatment of Patients With Chronic Hepatitis B With Hepatitis B Immunoglobulins Status TERMINATED Phase PHASE2
NCT05310487 Phase 1 Study of 162, a Novel Neutralizing Antibody Targeting Hepatitis B Surface Antigen, in Healthy Adult Subjects Status COMPLETED Phase PHASE1
NCT05298332 Ethnobridging Study in Healthy Volunteers, Chinese and Japanese Subjects Status TERMINATED Phase PHASE1
NCT05295914 Performance of Novel Simplified Score for Chronic Hepatitis B Treatment Eligibility in Thailand Status UNKNOWN Phase N/A
NCT05286346 Clinical Study to Evaluate the Safety and Efficacy of Switching to Tenofovir Disoproxil From Tenofovir Disoproxil Fumarate in Patients With Chronic Hepatitis B Status COMPLETED Phase PHASE4
NCT05282407 A phase4 Clinical Study to Evaluate the Safety and Efficacy of Switching to Tenofovir Disoproxil From Tenofovir Disoproxil Fumarate in Patients With Chronic Hepatitis B Status COMPLETED Phase PHASE4
NCT05273775 A Pharmacokinetic Study to Evaluate the Drug Interaction Between HRS5091 and Probe Drugs in Healthy Volunteers Status COMPLETED Phase PHASE1